Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1989-12-01
1991-12-24
Friedman, Stanley J.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514812, A61K 3144
Patent
active
050753410
ABSTRACT:
Mixed opiate agonist/antagonists, particularly buprenorphine, is provided for the treatment of cocaine dependence and concurrent cocaine and opiate abuse and dependence.
REFERENCES:
Chem. Abst.-110-166068t (1989).
Chem. Abst. 99-16461f (1983).
Lukas et al., Clin. Pharmacol. Ther. 36(1):127-132 (Jul. 1984).
Bickel et al., Journal of Pharmacol. and Exper. Therapeutics 247(1):47-53 (1988).
Kosten et al., Life Sciences 42:635-641 (1988).
O'Brien et al., J. Clin Psychiatry 49:2(Suppl):17-22 (Feb. 1988).
Gawin et al., The New England Journal of Medicine 318(18):1173-1182 (May 5, 1988).
Lukas et al., Journal of Pharmacol. and Exper. Therapeutics 238(3):924-931 (1986).
Kosten et al., Am. J. Drug Alcohol Abuse 12(1&2):1-16 (1986).
Kosten et al., Life Sciences 44:887-892 (1989).
Mello et al., "Buprenorphine Suppresses Cocaine Self-Administration in Rhesus Monkeys" (Abstract Only) (1989).
Kleber et al., J. Clin. Psychiatry 45:12(Sec. 2):18-23 (Dec. 1984).
Kosten et al., Arch. Gen. Psychiatry 44:281-284 (Mar. 1987).
Mello Nancy K.
Mendelson Jack H.
Friedman Stanley J.
The McLean Hospital Corporation
LandOfFree
Treatment for cocaine abuse does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Treatment for cocaine abuse, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment for cocaine abuse will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-43872